• Explore /
  • Poster
  • / Relationship of baseline PSA and degree of PSA decline to radiographic progression-free survival (rPFS) in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC): Results from COU-AA-302.

Relationship of baseline PSA and degree of PSA decline to radiographic progression-free survival (rPFS) in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC): Results from COU-AA-302.

Abstract Poster

Authors

Charles Ryan

Charles J. Ryan

Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA

Charles J. Ryan , Anil Londhe , Arturo Molina , Matthew R. Smith , Johann Sebastian De Bono , Peter Mulders , Dana E. Rathkopf , Fred Saad , Christopher Logothetis , Karim Fizazi , Howard I. Scher , Eric Jay Small , Shannon Matheny , Thian San Kheoh , Thomas W. Griffin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Genitourinary (Prostate) Cancer

Track

Genitourinary Cancer

Sub Track

Prostate Cancer

Clinical Trial Registration Number

NCT00887198

Citation

J Clin Oncol 31, 2013 (suppl; abstr 5010)

DOI

10.1200/jco.2013.31.15_suppl.5010

Abstract #

5010

Poster Bd #

2

Abstract Disclosures

Similar Posters

First Author: Evan Y. Yu

First Author: Robert Dreicer

First Author: Oscar B. Goodman Jr.

First Author: Yuchao Ni